CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Celltrion, Inc. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Celltrion, Inc.
23, Academy-ro, Yeonsu-gu
Phone: +82 216618722p:+82 216618722 INCHEON, 22014  South Korea Ticker: 068270068270

Business Summary
Celltrion Inc is a Korea-based company mainly engaged in the production and sale of bio pharmaceuticals. The Company operates its business through two segments. The Bio Pharmaceutical segment is mainly engaged in the development, production and sale of biosimilar products. The Chemical Pharmaceutical segment is mainly engaged in the manufacture and sale of chemical drugs. In addition, the Segment sells bio and chemical drugs, and provides services such as data analysis. The Company's main products include liver and bowel medicines and other generics. The main merchants sold by the Company include autoimmune disease treatment agents, anti-malignant tumor drugs, anti-malignant tumor drugs, and other merchants. The Company sells its products in domestic and overseas markets such as Europe and the United States.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
3/31/202012/31/2019Yes----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman of the Board Jung JinSeo 62 1/1/2018 7/17/2008
Chief Executive Officer, Director Woo SungKee 58 1/1/2017 1/1/2008
Senior Vice President Sin JaeJang 55 1/1/2017 1/1/2008
7 additional Officers and Directors records available in full report.

Business Names
Business Name
068270
CONIF
OR CHEM Co., Ltd
sdchemical co.ltd

General Information
Number of Employees: 1,074 (As of 12/31/2015)
Outstanding Shares: 133,726,470 (As of 5/22/2020)
Shareholders: 226,141
Stock Exchange: SEO
Fax Number: +82 328505078


Copyright © 2020 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, August 11, 2020